U.S. Agency for International Development Chief Innovation Officer Steven VanRoekel said the region’s ability to respond to the crisis was hampered by a crippling lack of infrastructure.
Federal officials talk about how private industry can help meet the needs of the federal government.
Ebola may not be getting the media attention it did a few short months ago, but it’s still ravaging West Africa. And now the CDC is piloting a tool that merges health, population and movement data to predict the spread of the disease.
A working group of more than 40 government agencies and nonprofits is asking for the public’s help in crafting a guide that details the best ways for the government to engage and collaborate with its citizens.
Millions of Americans swear by their fitness apps and wearable health tracking devices. But researchers at the National Cancer Institute are hesitant to conclude this wearable tech revolution is clinically effective.
FDA’s first chief health informatics officer envisions a future where health care could be better tailored to the patent.
Lawmakers got their chance Tuesday to question former U.S. Chief Technology Officer Todd Park about his involvement in the botched rollout of Healthcare.gov. And while Republicans focused on his accountability as a leader, Democrats expressed fear that his forced testimony could discourage private innovators from helping with the government’s major technology undertakings.
The Centers for Medicare and Medicaid Services has hired a chief data officer to lead a new data-focused office overseeing the use of the agency’s wealth of health data.
IDEA Lab announced a new cohort for its Entrepreneurs-In-Residence program, which matches entrepreneurs from outside government with HHS employees to innovate on “high risk high reward projects” crowdsourced from within the agency.
The nation has made tremendous improvements in growing its health IT infrastructure in the past decade, and the topic is continuing to grow as a critical focus in the federal health care community. But ONC recognizes that it will all be for naught if the technology and systems don’t achieve the end goal of improving the care quality patients are receiving.
Come Nov. 15, all eyes will return to Healthcare.gov with memories of last year’s flawed technological launch top of mind as the the Affordable Care Act’s second enrollment period begins. But this time around, President Barack Obama and his Healthcare.gov team are confident that things will be different.
FedRAMP gave the OK for Verizon’s enterprise cloud service to operate as a provider for HHS. Verizon was one the first cloud offerings available to the government.
The HHS Buyers Club, a platform looking to revolutionize the way the agency acquires new IT systems, has launched its official website.
After news last week that Karen DeSalvo, national coordinator for health IT, was asked to join the Department of Health and Human Services as acting assistant secretary of health, the Office of the National Coordinator for Health IT has clarified that she will not relinquish the leadership duties of her former post.
As the FDA receives more cybersecurity risk assessments for medical devices, “there will be a repertoire that we identify with and then look for in other submissions,” an FDA official said.
House Science Committee Republicans want the former federal chief technology officer to answer questions about his role in the launch of HealthCare.gov.
The national coordinator for health IT, Karen DeSalvo, is stepping down from her role to take over as acting assistant secretary for health in the Department of Health and Human Services.
Patient-focused health care is about quality not quantity. So the Department of Health and Human Services is offering $840 million over the next four years to clinicians who focus more on quality care than volume using various tools and strategies, including some rooted in IT, to ensure more positive patient outcomes.
An audit of the FDA’s computer network immediately after a cybersecurity breach last year detected vulnerabilities in the agency’s system.
The FDA issued new guidance that aims to clarify whether a change in a medical device may require a recall – or is simply an “enhancement.” According to a notice published last week in the Federal Register, companies may have trouble determining whether an update to their product meets the criteria for a recall. The guidance formally defines an enhancement and presents a Q-and-A as well as sample scenarios to illustrate its recommendations. “It will make the process of determining whether a modification is an enhancement that much clearer, and companies can proceed with more confidence that they’re doing the right…